Cargando…

Multiple Sclerosis, Viruses, and New Vaccines

Detalles Bibliográficos
Autor principal:	Maple, Peter A. C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706313/ https://www.ncbi.nlm.nih.gov/pubmed/34940754 http://dx.doi.org/10.3390/neurolint13040068

Ejemplares similares

An Absence of Epstein–Barr Virus Reactivation and Associations with Disease Activity in People with Multiple Sclerosis Undergoing Therapeutic Hookworm Vaccination
por: Maple, Peter A. C., et al.
Publicado: (2020)

The Potential for EBV Vaccines to Prevent Multiple Sclerosis
por: Maple, Peter A., et al.
Publicado: (2022)

Vaccine hesitancy in people with multiple sclerosis
por: Lechner-Scott, Jeannette S, et al.
Publicado: (2022)

Herpesvirus Vaccines
por: Petrini, Stefano, et al.
Publicado: (2022)

COVID-19 vaccines and multiple sclerosis disease-modifying therapies
por: Giovannoni, Gavin, et al.
Publicado: (2021)

Epstein–Barr virus and multiple sclerosis: the dawn of a new age
por: Phan, Tri Giang
Publicado: (2023)

Multiple Sclerosis
por: Ramagopalan, Sreeram, et al.
Publicado: (2011)

A new dawn for genetic association studies in multiple sclerosis
por: Kantarci, Orhun H.
Publicado: (2016)

Multiples sclerosis in India
por: Khadilkar, Satish V.
Publicado: (2015)

Multiple Sclerosis in India
por: Goyal, Vinay
Publicado: (2018)

Disease Activity and Progression in Multiple Sclerosis: New Evidences and Future Perspectives
por: Del Negro, Ilaria, et al.
Publicado: (2022)

WITHDRAWN: Vaccination of multiple sclerosis patients during the COVID-19 era: Novel insights into vaccine safety and immunogenicity
por: Kim, Enoch, et al.
Publicado: (2022)

Cytomegalovirus and Epstein–Barr Virus Associations with Neurological Diseases and the Need for Vaccine Development
por: Maple, Peter A. C.
Publicado: (2020)

Outcome Measures in Multiple Sclerosis
por: Bermel, Robert, et al.
Publicado: (2014)

IL-11 in multiple sclerosis
por: Zhang, Xin, et al.
Publicado: (2015)

Advances in Multiple Sclerosis 2017
por: Göbel, Kerstin, et al.
Publicado: (2018)

Molecular Research in Multiple Sclerosis
por: Fucito, Maurine, et al.
Publicado: (2022)

Multiple Sclerosis: From Molecules to Treatment
por: Broadley, Simon A
Publicado: (2013)

Improving communication with multiple sclerosis patients
por: Alroughani, Raed A.
Publicado: (2015)

Cellular and Molecular Mechanisms in the Pathogenesis of Multiple Sclerosis
por: Wan, Edwin C. K.
Publicado: (2020)

Digital Innovation in Multiple Sclerosis Management
por: Ziemssen, Tjalf, et al.
Publicado: (2021)

Sequencing the immunopathologic heterogeneity in multiple sclerosis
por: Antel, Jack P, et al.
Publicado: (2015)

Personalized Diagnosis and Therapy for Multiple Sclerosis
por: Ramo-Tello, Cristina
Publicado: (2022)

Response of the multiple sclerosis community to COVID-19
por: Ciccarelli, Olga, et al.
Publicado: (2020)

Molecule of the month: miRNA and Multiple Sclerosis
por: Shapshak, Paul
Publicado: (2013)

Remyelination therapy goes to trial for multiple sclerosis
por: Brugarolas, Pedro, et al.
Publicado: (2014)

Neuropsychological Features of Multiple Sclerosis: Impact and Rehabilitation
por: Messinis, Lambros, et al.
Publicado: (2018)

Prospects of siponimod in secondary progressive multiple sclerosis
por: McGinley, Marisa, et al.
Publicado: (2018)

The Long Road of Immunotherapeutics against Multiple Sclerosis †
por: Apostolopoulos, Vasso, et al.
Publicado: (2020)

Advances in Multiple Sclerosis Research–Series I
por: Apostolopoulos, Vasso, et al.
Publicado: (2020)

The relationship between multiple sclerosis and neuropsychiatric syndromes
por: McLoughlin, James, et al.
Publicado: (2017)

Multiple Sclerosis: Diagnosis, Management, and Future Opportunities
por: Maida, Elisabetta, et al.
Publicado: (2023)

Fatigue and Affective Manifestations in Multiple Sclerosis—A Cluster Approach
por: Ayache, Samar S., et al.
Publicado: (2019)

Multiple sclerosis in Isfahan, Iran: Past, Present and Future
por: Etemadifar, Masoud, et al.
Publicado: (2012)

Progress and Roadblocks Along the Pathway to Multiple Sclerosis Treatment
Publicado: (2015)

TLR2 – an innate immune checkpoint in multiple sclerosis
por: Hossain, Md Jakir, et al.
Publicado: (2015)

Multiple sclerosis in the Middle East and North Africa region
por: Khoury, Samia J, et al.
Publicado: (2020)

Editorial to Special Issue “Cognitive Involvement in Multiple Sclerosis”
por: Lanzillo, Roberta
Publicado: (2022)

The dynamics of the immune system and gut in the pathophysiology of multiple sclerosis
por: eBioMedicine
Publicado: (2022)

Multiple sclerosis at the crossroads of scientific evidence and clinical translation
por: Sellner, Johann
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5cthro0vtbap15rvhniri83puh